Globe Life (NYSE:GL) Price Target Raised to $180.00

Globe Life (NYSE:GL) had its price target upped by Truist Financial from $158.00 to $180.00 in a research note issued to investors on Friday,Benzinga reports. Truist Financial currently has a buy rating on the stock.

A number of other research firms also recently issued reports on GL. TD Cowen reissued a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday. Piper Sandler restated an “overweight” rating and set a $167.00 price target on shares of Globe Life in a research note on Friday, November 21st. Wells Fargo & Company lowered their price target on Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research report on Friday, October 24th. Finally, Keefe, Bruyette & Woods lifted their price objective on Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $171.00.

Globe Life Stock Performance

Shares of Globe Life stock opened at $146.62 on Friday. The firm has a market cap of $11.67 billion, a PE ratio of 10.41 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life has a 52 week low of $109.38 and a 52 week high of $152.71. The business’s fifty day simple moving average is $139.38 and its 200-day simple moving average is $138.17.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the business posted $3.14 earnings per share. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities analysts forecast that Globe Life will post 13.87 earnings per share for the current year.

Insider Activity

In other news, CEO Frank M. Svoboda sold 9,379 shares of the stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total value of $1,317,092.97. Following the sale, the chief executive officer directly owned 35,868 shares in the company, valued at approximately $5,036,943.24. This trade represents a 20.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.97% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in shares of Globe Life by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after buying an additional 86,349 shares during the period. Invesco Ltd. increased its stake in shares of Globe Life by 3.9% during the second quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock worth $487,396,000 after buying an additional 147,644 shares during the period. Geode Capital Management LLC raised its holdings in Globe Life by 2.9% in the second quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock valued at $339,875,000 after acquiring an additional 76,995 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Globe Life by 2.9% in the third quarter. Dimensional Fund Advisors LP now owns 2,076,232 shares of the company’s stock worth $296,841,000 after acquiring an additional 59,353 shares during the last quarter. Finally, AQR Capital Management LLC lifted its stake in Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after acquiring an additional 696,548 shares during the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.